Trial Profile
A Prospective Randomised Controlled Trial on the Use of BMP-7 (OP-1) and Demineralised Bone Matrix in Tibial Non-union
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Eptotermin alfa (Primary)
- Indications Non-union fracture
- Focus Therapeutic Use
- 07 Jul 2021 Status changed from suspended to discontinued.
- 10 Jul 2012 Planned end date changed from 1 Dec 2011 to 1 Jul 2012 as reported by ClinicalTrials.gov.
- 10 Jul 2012 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.